{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:06:20Z","timestamp":1778583980123,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED)","award":["A102063"],"award-info":[{"award-number":["A102063"]}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.coph.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T03:32:06Z","timestamp":1403321526000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology"],"prefix":"10.1016","volume":"19","author":[{"given":"Napapan","family":"Kangwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Baik","family":"Hahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2014.06.003_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0092-8674(95)90126-4","article-title":"Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration","volume":"83","author":"Langenbach","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.06.003_bib0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","article-title":"Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse","volume":"83","author":"Morham","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.06.003_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/378406a0","article-title":"Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II","volume":"378","author":"Dinchuk","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.06.003_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s100670070024","article-title":"COX-2-specific inhibitors\u2014the emergence of a new class of analgesic and anti-inflammatory drugs","volume":"19","author":"Everts","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coph.2014.06.003_bib0025","first-page":"96","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2014.06.003_bib0030","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2014.06.003_sbref0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(10)60673-3","article-title":"Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial","volume":"376","author":"Chan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2014.06.003_sbref0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.gastro.2008.05.030","article-title":"Gastric mucosal defense and cytoprotection: bench to bedside","volume":"135","author":"Laine","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2014.06.003_bib0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI200113418","article-title":"Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs","volume":"108","author":"Patrono","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2014.06.003_bib0050","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1440-1746.2009.05929.x","article-title":"Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage","volume":"24","author":"Lim","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2014.06.003_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1163\/156856005774423809","article-title":"Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing","volume":"13","author":"Peskar","year":"2005","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.coph.2014.06.003_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0928-4257(01)00005-5","article-title":"Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs","volume":"95","author":"Tanaka","year":"2001","journal-title":"J Physiol Paris"},{"key":"10.1016\/j.coph.2014.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v19.i12.1861","article-title":"Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy","volume":"19","author":"Wallace","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0070","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbalip.2012.04.002","article-title":"Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine","volume":"1821","author":"Lichtenberger","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2014.06.003_bib0075","doi-asserted-by":"crossref","first-page":"C800","DOI":"10.1152\/ajpcell.00157.2008","article-title":"Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7","volume":"295","author":"Oshima","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.coph.2014.06.003_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2006.10.023","article-title":"Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats","volume":"554","author":"Funatsu","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_bib0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.111.190116","article-title":"Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing","volume":"342","author":"Colucci","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.06.003_bib0090","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0016-5085(98)70328-2","article-title":"Leukocyte\u2013endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease","volume":"114","author":"Panes","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2014.06.003_bib0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-2952(98)00330-X","article-title":"Inhibition and uncoupling of oxidative phosphorylation by nonsteroidal anti-inflammatory drugs: study in mitochondria, submitochondrial particles, cells, and whole heart","volume":"57","author":"Moreno-Sanchez","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_bib0100","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3748\/wjg.v18.i18.2147","article-title":"Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility","volume":"18","author":"Takeuchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/jpet.112.197475","article-title":"Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility","volume":"343","author":"Satoh","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.06.003_bib0110","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1124\/mol.105.015784","article-title":"Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs","volume":"68","author":"Ushijima","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_bib0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/egh.10.25","article-title":"Rebamipide: a gastrointestinal protective drug with pleiotropic activities","volume":"4","author":"Naito","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0120","first-page":"106","article-title":"Irsogladine: overview of the mechanisms of mucosal protective and healing-promoting actions in the gastrointestinal tract","volume":"19","author":"Akagi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coph.2014.06.003_sbref0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.113.208991","article-title":"Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats","volume":"348","author":"Satoh","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.06.003_bib0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm0295-154","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury","volume":"1","author":"Lichtenberger","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2014.06.003_sbref0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1358\/dot.2009.45.12.1441075","article-title":"Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity","volume":"45","author":"Lichtenberger","year":"2009","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.coph.2014.06.003_bib0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1248\/cpb.60.465","article-title":"NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs","volume":"60","author":"Borhade","year":"2012","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.coph.2014.06.003_sbref0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2006.11.042","article-title":"Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2014.06.003_sbref0150","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00169.2013","article-title":"Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments","volume":"305","author":"Chan","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2014.06.003_bib0155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.freeradbiomed.2006.12.011","article-title":"Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative","volume":"42","author":"Li","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.coph.2014.06.003_bib0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2012.09.049","article-title":"Docosahexaenoic acid, an omega-3 polyunsaturated acid protects against indomethacin-induced gastric injury","volume":"697","author":"Pineda-Pena","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0165","doi-asserted-by":"crossref","DOI":"10.1038\/427504a","article-title":"Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids","volume":"427","author":"Kang","year":"2004","journal-title":"Nature"},{"issue":"Suppl 58","key":"10.1016\/j.coph.2014.06.003_bib0170","first-page":"OL1757","article-title":"G-protein coupled receptor 120 is involved in glucose metabolism in fat cells","author":"Liu","year":"2012","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.coph.2014.06.003_bib0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2007.01.001","article-title":"Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation","volume":"46","author":"Kang","year":"2007","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.coph.2014.06.003_sbref0180","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.cdd.4401436","article-title":"Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis","volume":"11","author":"Tsutsumi","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.coph.2014.06.003_bib0185","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bcp.2011.03.019","article-title":"Sulindac sulfide induces autophagic death in gastric epithelial cells via survivin down-regulation: a mechanism of NSAIDs-induced gastric injury","volume":"81","author":"Chiou","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0190","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2007.07.024","article-title":"NSAIDs enhance proteasomic degradation of survivin, a mechanism of gastric epithelial cell injury and apoptosis","volume":"74","author":"Chiou","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2004.10.008","article-title":"Survivin: a novel target for indomethacin-induced gastric injury","volume":"128","author":"Chiou","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2014.06.003_bib0200","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-230X-12-143","article-title":"A possible involvement of Nrf2-mediated heme oxygenase-1 up-regulation in protective effect of the proton pump inhibitor pantoprazole against indomethacin-induced gastric damage in rats","volume":"12","author":"Lee","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.coph.2014.06.003_bib0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0891-5849(96)00406-6","article-title":"Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells","volume":"22","author":"Hahm","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.coph.2014.06.003_bib0210","doi-asserted-by":"crossref","first-page":"27622","DOI":"10.1074\/jbc.M610778200","article-title":"Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner","volume":"282","author":"Jang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.06.003_bib0215","first-page":"157","article-title":"Nonsteroidal anti-inflammatory drugs (NSAID) sparing effects of glucosamine hydrochloride through N-glycosylation inhibition; strategy to rescue stomach from NSAID damage","volume":"64","author":"Park","year":"2013","journal-title":"J Physiol Pharmacol"},{"issue":"Suppl 7","key":"10.1016\/j.coph.2014.06.003_bib0220","first-page":"5","article-title":"Role of heat shock proteins in gastric inflammation and ulcer healing","volume":"60","author":"Choi","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_bib0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1751-2980.2011.00482.x","article-title":"Acid pump antagonist-provoked HSP27 dephosphorylation and accentuation rescues stomach from indomethacin-induced damages","volume":"12","author":"Ock","year":"2011","journal-title":"J Dig Dis"},{"key":"10.1016\/j.coph.2014.06.003_bib0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1017\/S000711450888871X","article-title":"The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology","volume":"100","author":"Tiihonen","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.coph.2014.06.003_bib0235","doi-asserted-by":"crossref","first-page":"G506","DOI":"10.1152\/ajpgi.90553.2008","article-title":"Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid","volume":"297","author":"Watanabe","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2014.06.003_bib0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2013.02.010","article-title":"Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of alpha-defensin 5","volume":"704","author":"Tanigawa","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2014.06.003_sbref0245","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2011.06.075","article-title":"Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis","volume":"141","author":"Wallace","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921400054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921400054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T02:00:07Z","timestamp":1538532007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148921400054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":49,"alternative-id":["S147148921400054X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2014.06.003","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}